Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2023-11-03 00:00:00 ET · period of report 2023-11-01 · accession 0001415889-23-014792 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-11-03 | 2023-11-01+ | OLMA | Myles David C. | CH. DISCOV, NON-CLIN DEV OFF | S - Sale | $15.26 | -10.5K | 561.5K | -2% | -$160.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-01 | S | D | 6,668 | $15.02 | 565,343 | D | — | — | (F2) The weighted average sale price for the transaction reported was $15.02, and the range of prices were between $15.00 and $15.09. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2023-11-02 | S | D | 3,332 | $15.36 | 562,011 | D | — | — | (F3) The weighted average sale price for the transaction reported was $15.36, and the range of prices were between $15.01 and $15.74. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 3 | Common | Common Stock | 2023-11-03 | S | D | 541 | $17.51 | 561,470 | D | — | — | (F4) The weighted average sale price for the transaction reported was $17.51, and the range of prices were between $17.50 and $17.53. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |